Skip to main navigation
Prelude Therapeutics
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • JAK2V617F
    • KAT6A
    • Precision DACs
    • Discovery Engine
    • Publications
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact

Committee Composition

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • JAK2V617F
    • KAT6A
    • Precision DACs
    • Discovery Engine
    • Publications
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact
Director Name Audit Committee Compensation Committee Nominating and Corporate Governance Committee
Martin Babler member of Audit Committee member of Compensation Committee
Katina Dorton chairperson of Audit Committee
David Bonita member of Audit Committee chairperson of Compensation Committee
Paul Friedman Chairman of the Board member of Nominating and Corporate Governance Committee
Paul Scherer member of Compensation Committee member of Nominating and Corporate Governance Committee
Victor Sandor chairperson of Nominating and Corporate Governance Committee
Legend = Chairperson = Member = Chairman of the Board
Print Page
RSS Feeds
Email Alerts
Search
preludetx.com

© Prelude Therapeutics
175 Innovation Blvd
Wilmington, DE 19805
(302) 467-1280

  • About
  • Science
  • Investors
  • News
  • Life at Prelude
  • Contact
visit our Twitter page visit our LinkedIn page Terms of Use Privacy Policy
logo
  • About
    • Overview
    • Leadership
    • Board of Directors
  • Science
    • Overview
    • Pipeline
    • JAK2V617F
    • KAT6A
    • Precision DACs
    • Discovery Engine
    • Publications
  • Investors
    • Overview
    • News & Events
      • News Releases
      • Events & Presentations
    • Financials
      • SEC Filings
      • Quarterly Results
    • Stock Information
      • Stock Quotes & Charts
      • Analysts
    • Governance
      • Governance Documents
      • Leadership
      • Committee Composition
    • Investor Resources
      • Investor FAQ's
      • Contact IR
      • Email Alerts
  • News
  • Life at Prelude
    • Overview
    • Open Positions
  • Contact